The company said, “Merit also announced preliminary unaudited revenue in the range of approximately $380 to $384 million for the quarter ended June 30, 2025, a projected increase of approximately 12% to 14% compared to revenue reported for the quarter ended June 30, 2024. Preliminary constant currency revenue for the quarter ended June 30, 2025, increased in the range of approximately 11% to 13% compared to the prior year period.”
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MMSI:
- Merit Medical CEO sells $1.93M shares of shares
- Positive Outlook for Merit Medical Systems Amid Tariff Reductions and Resilient Growth
- Merit Medical price target raised to $110 from $106 at Piper Sandler
- Merit Medical price target raised to $112 from $108 at Canaccord
- Merit Medical price target raised to $108 from $106 at Wells Fargo